Literature DB >> 7959096

The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva.

H Mietz1, U Niesen, G K Krieglstein.   

Abstract

BACKGROUND: Topical medication applied chronically for the treatment of glaucoma changes the cellular profile of the conjunctiva. We wanted to determine the role of preservatives, which are usually combined with the drugs, on this effect.
METHODS: We applied metipranolol 0.3% and pilocarpine 2% with and without benzalkonium chloride 0.01% and cetrimonium chloride 0.004%, respectively. Twenty-four rabbits, divided into four groups, were treated for 3 months. The complete globes and the adherent bulbar conjunctiva were examined histopathologically and immunohistochemically.
RESULTS: With special stains for collagen, a slight increase of the thickness of subepithelial collagen of the conjunctiva was present in both groups treated with medication and preservative compared with eyes treated with medication alone. This effect was also true for special antibodies for collagen type IV and alpha-smooth muscle actin in the eyes treated with pilocarpine, but not in the eyes treated with metipranolol.
CONCLUSION: The results suggest that preservatives may have an additional adverse effect on the conjunctiva in addition to the effects of the medications alone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959096     DOI: 10.1007/BF00182000

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  External filtering operations for glaucoma: the mechanism of function and failure.

Authors:  A E MAUMENEE
Journal:  Trans Am Ophthalmol Soc       Date:  1960

2.  Histology and mechanism of filtering operations.

Authors:  C C TENG; H H CHI; H M KATZIN
Journal:  Am J Ophthalmol       Date:  1959-01       Impact factor: 5.258

3.  The influence of prior therapy on the success of trabeculectomy.

Authors:  M J Lavin; R P Wormald; C S Migdal; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1990-11

4.  Effects of timolol, betaxolol, and levobunolol on human tenon's fibroblasts in tissue culture.

Authors:  D E Williams; K D Nguyen; S Shapourifar-Tehrani; S Kitada; D A Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-06       Impact factor: 4.799

5.  Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients.

Authors:  M B Sherwood; I Grierson; L Millar; R A Hitchings
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

Review 6.  Adverse effects of topical antiglaucomatous medications on the conjunctiva.

Authors:  D Broadway; I Grierson; R Hitchings
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

7.  Short- and long-term effects of postoperative corticosteroids on trabeculectomy.

Authors:  R J Starita; R L Fellman; G L Spaeth; E M Poryzees; K C Greenidge; C E Traverso
Journal:  Ophthalmology       Date:  1985-07       Impact factor: 12.079

8.  Effects of topical glaucoma drugs on fistulized rabbit conjunctiva.

Authors:  T L Young; E J Higginbotham; X L Zou; M D Farber
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

9.  The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: five-year follow-up study.

Authors:  S M Roth; G L Spaeth; R J Starita; E M Birbillis; W C Steinmann
Journal:  Ophthalmic Surg       Date:  1991-12

10.  The effects of glaucoma medications on Tenon's capsule and conjunctiva in the rabbit.

Authors:  D L Smith; G L Skuta; M C Kincaid; R Rabbani; D F Cruess; S F Kao
Journal:  Ophthalmic Surg       Date:  1991-06
View more
  21 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.

Authors:  L Malvitte; T Montange; A Vejux; C Baudouin; A M Bron; C Creuzot-Garcher; G Lizard
Journal:  Br J Ophthalmol       Date:  2006-08-30       Impact factor: 4.638

3.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

4.  Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery.

Authors:  Silke Berthold; Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-08       Impact factor: 3.117

5.  Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.

Authors:  C Baudouin; C de Lunardo
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

Review 6.  PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.

Authors:  Mihaela Cristina Coroi; Simona Bungau; Mirela Tit
Journal:  Rom J Ophthalmol       Date:  2015 Jan-Mar

7.  Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

Authors:  P J Pisella; P Pouliquen; C Baudouin
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

8.  The additive effects on intraocular pressure of combining nipradilol 0.25% and latanoprost 0.005% ophthalmic solutions: a prospective, randomized, multicenter study.

Authors:  Tadahiko Tsuru; Yoshiaki Kitazawa; Masahiko Usui; Satoki Ueno; Ikuo Azuma; Kanjiro Masuda
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

9.  Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients.

Authors:  Michael B Horsley; Malik Y Kahook
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.

Authors:  Dorota Pozarowska
Journal:  Clin Ophthalmol       Date:  2010-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.